Supplemental Table 2 from First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer
| Autor: | Josep Tabernero, Irene Braña, Maria Alsina, Jorge D. Gallo, Brett E. Houk, Lixin Han, Kristen J. Pierce, Gary Borzillo, Robert Millham, Susan S. Pandya, Eunice L. Kwak, James Spicer, Johanna Bendell, Julian R. Molina, Katherine M. Bell-McGuinn, Geoffrey I. Shapiro |
|---|---|
| Rok vydání: | 2023 |
| Popis: | Supplemental Table 2. Additional study results on treatment-related adverse events at dose levels above the maximum tolerated dose |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|